Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

References for PMC Articles for PubMed (Select 18191742)

1.

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV.

Chest. 2007 Jun;131(6):1917-28.

PMID:
17565025
2.

CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children.

Chaudry G, MacDonald C, Adatia I, Gundogan M, Manson D.

Pediatr Radiol. 2007 Apr;37(4):345-50. Epub 2007 Feb 6.

PMID:
17279402
3.

[Pulmonary hypertension associated with congenital heart disease].

Beghetti M.

Rev Mal Respir. 2006 Sep;23(4 Suppl):13S49-59; quiz 13S157, 13S159. Review. French.

PMID:
17057631
4.

Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.

Mukhopadhyay S, Sharma M, Ramakrishnan S, Yusuf J, Gupta MD, Bhamri N, Trehan V, Tyagi S.

Circulation. 2006 Oct 24;114(17):1807-10. Epub 2006 Oct 9.

5.

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.

Hoeper MM, Leuchte H, Halank M, Wilkens H, Meyer FJ, Seyfarth HJ, Wensel R, Ripken F, Bremer H, Kluge S, Hoeffken G, Behr J.

Eur Respir J. 2006 Oct;28(4):691-4.

6.

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension.

McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ.

Am J Respir Crit Care Med. 2006 Dec 1;174(11):1257-63. Epub 2006 Aug 31.

PMID:
16946127
7.

Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.

Sitbon O, Beghetti M, Petit J, Iserin L, Humbert M, Gressin V, Simonneau G.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:25-31.

PMID:
16919007
8.

Survival in patients with pulmonary arterial hypertension treated with first-line bosentan.

McLaughlin VV.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:10-5.

PMID:
16919005
9.

Pulmonary flow reserve in children with idiopathic pulmonary arterial hypertension: implications for diagnosis and therapy.

Zimmermann R, Kreuder J, Michel-Behnke I, Voelkel NF, Schranz D.

Eur J Med Res. 2006 May 5;11(5):208-13.

PMID:
16723295
10.

Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension.

Simpson CM, Penny DJ, Cochrane AD, Davis AM, Rose ML, Wilson SE, Weintraub RG.

J Heart Lung Transplant. 2006 Apr;25(4):469-73. Epub 2006 Feb 28.

PMID:
16563979
11.

Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.

Berman Rosenzweig E, Barst RJ.

Treat Respir Med. 2006;5(2):117-27.

PMID:
16512692
12.

Sildenafil citrate therapy for pulmonary arterial hypertension.

Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group.

N Engl J Med. 2005 Nov 17;353(20):2148-57. Erratum in: N Engl J Med. 2006 Jun 1;354(22):2400-1.

13.

Response to bosentan in children with pulmonary hypertension.

Maiya S, Hislop AA, Flynn Y, Haworth SG.

Heart. 2006 May;92(5):664-70. Epub 2005 Oct 10.

14.

Effects of long-term bosentan in children with pulmonary arterial hypertension.

Rosenzweig EB, Ivy DD, Widlitz A, Doran A, Claussen LR, Yung D, Abman SH, Morganti A, Nguyen N, Barst RJ.

J Am Coll Cardiol. 2005 Aug 16;46(4):697-704.

15.

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.

Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, Humbert M, Rainisio M, Rubin LJ, Simonneau G.

Thorax. 2005 Dec;60(12):1025-30. Epub 2005 Jul 29.

16.
17.

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

Galiè N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J; Task Force.

Eur Heart J. 2004 Dec;25(24):2243-78. No abstract available.

18.

Treatment of pulmonary arterial hypertension.

Humbert M, Sitbon O, Simonneau G.

N Engl J Med. 2004 Sep 30;351(14):1425-36. Review. No abstract available.

PMID:
15459304
19.

Outcomes in children with idiopathic pulmonary arterial hypertension.

Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ.

Circulation. 2004 Aug 10;110(6):660-5. Epub 2004 Aug 2.

20.

Diagnosis and differential assessment of pulmonary arterial hypertension.

Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S.

J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):40S-47S. Review.

PMID:
15194177
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk